
Shire, the major healthcare company listed in London, is in the news as the American pharmaceutical company AbbVie attempts to get Shire’s board to recommend its attempt to buy it. This comes hot on the heels of the failed attempt by AbbVie’s bigger US peer, Pfizer, to acquire Shire’s bigger UK peer, AstraZeneca. Since this seems to be part of a rush by cash rich…